Project Grant R03DK147547
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Pennsylvania a $787,367 Project Grant on September 9, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to map the gene regulatory architecture of pancreatic islet-specific cell types in relation to diabetes. The project, scheduled for completion by June 30, 2030, will create the largest integrated map of islet cell...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $175,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 20, 2026, with a completion date of April 30, 2028. The award funds basic biomedical research focused on spatial profiling of pancreatic N-glycosylation in Type 1 Diabetes (T1D), addressing critical...
- Federal Project Grant Award Summary The Ohio State University received a $249,001 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, through March 31, 2029. This award supports basic biomedical research investigating the regulation and maintenance of adipose tissue T cells (ATTs) and their role in obesity-related metabolic...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $754,682 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026 through April 30, 2030. This research initiative addresses beta cell dysfunction in Type 1 Diabetes (T1D) by investigating the metabolic and immunological mechanisms...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $786,216 Project Grant to the University of California, Los Angeles (UCLA) on August 28, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a four-year research initiative (through June 30, 2029) investigating post-transcriptional regulation of hepatokines and systemic metabolism. The research focuses on identifying...
- Federal Grant Award Summary The Ohio State University received a $236,250 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on September 15, 2025, with a completion date of August 31, 2027. The award supports research investigating nutrient regulation of the enteroendocrine cell (EEC)-vagal network, focusing on how cholecystokinin (CCK)-expressing...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $797,416 Project Grant to The Regents of the University of Colorado (University of Colorado-Denver) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period April 1, 2026 through March 31, 2029. The award funds research investigating the immunogenetic mechanisms underlying Type 1 Diabetes (T1D) etiology and pathogenesis,...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Scripps Research Institute a $801,662 Project Grant effective August 15, 2025, through June 30, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project investigates the initiation of anti-islet autoimmunity in Type 1 Diabetes (T1D), a CD4 T cell-mediated autoimmune disease, with particular focus on understanding the role...
- Federal Grant Award Summary The University of Virginia received a $1.44 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026 through April 30, 2029. This ancillary research project examines the role of alternative splicing in the initiation and progression of islet autoimmunity as part of the Environmental Determinants of...
- Federal Project Grant Award Summary The University of Michigan, Ann Arbor, received a $1,363,124 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 21, 2025, through April 30, 2029. This award funds research to advance metabolic maturity of islet organoids derived from human pluripotent stem cells (HPSC) for Type 1 Diabetes treatment. The...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Ohio State University a $157,500 Project Grant on May 22, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on spatial lipid-gene relationships underlying Type 1 Diabetes (T1D). The project, which runs through February 28, 2028, will employ an integrated multimodal imaging pipeline combining imaging mass spectrometry, liquid chromatography mass spectrometry, Xenium spatial transcriptomics, and multiplexed immunofluorescence to spatially map lipid species alongside RNA and protein markers in human pancreatic tissue samples from the Vanderbilt Pancreas Biorepository. The research will identify cell-type- and niche-specific lipid changes associated with T1D by co-registering and analyzing spatial datasets in collaboration with PankBase, a public research resource. The primary deliverable will be a comprehensive spatial dataset integrating lipid signatures with transcriptional and protein information, formatted for ingestion into the PankBase public database to support the Type 1 Diabetes research community and advance NIDDK's strategic goals in molecular tissue atlasing. This research is designed to improve understanding of disease mechanisms and contribute to enhanced prevention and treatment strategies for Type 1 Diabetes through mechanistic insights into pancreatic lipid alterations during disease progression.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $157.5k | 5/26/26 |